Effect of High-Flow Nasal Cannula versus Conventional Oxygen Therapy for Patients with Thoracoscopic Lobectomy after Extubation

Yuetian Yu, Xiaozhe Qian, Chunyan Liu, Cheng Zhu, Yuetian Yu, Xiaozhe Qian, Chunyan Liu, Cheng Zhu

Abstract

Objective. To investigate whether high-flow nasal cannula (HFNC) oxygen therapy is superior to conventional oxygen therapy for reducing hypoxemia and postoperative pulmonary complications (PPC) in patients with thoracoscopic lobectomy after extubation. Methods. Patients with intermediate to high risk for PPC were enrolled in this study. Subjects were randomly assigned to HFNC group (HFNCG) or conventional oxygen group (COG) following extubation. Arterial blood samples were collected after extubation at 1, 2, 6, 12, 24, 48, and 72 h. Patients with postoperative hypoxemia and PPC were recorded. Adverse events were also documented. Results. Totally 110 patients were randomly assigned to HFNCG (n = 56) and COG (n = 54). The occurrence rate of hypoxemia in COG was twice more than that in HFNCG (29.62% versus 12.51%, P < 0.05) and PaO2, PaO2/FiO2, and SaO2/FiO2 were significantly improved in HFNCG (P < 0.05) in the first 72 h following extubation. Respiratory rate and incidence of reintubation as well as needing noninvasive ventilation were also decreased in HFNCG (P < 0.05), whereas the incidence of pneumonia and atelectasis were similar (P > 0.05). Adverse effects as throat and nasal pain occurred more frequently in COG. Conclusions. HFNC application improves oxygenation and reduces the risk of reintubation following thoracoscopic lobectomy but cannot decrease the incidence of PPC.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
Comparison of variables between two groups in different time points. (a) Arterial PaO2 values; (b) arterial PaCO2 values; (c) the PaO2/fractional inspired oxygen (FiO2) ratio; (d) oxygen saturation/FiO2 ratio; (e) lactate values; (f) respiratory rate. ∗P < 0.05.

References

    1. Tu C.-C., Hsu P.-K. Global development and current evidence of uniportal thoracoscopic surgery. Journal of Thoracic Disease. 2016;8:S308–S318. doi: 10.3978/j.issn.2072-1439.2016.02.53.
    1. Licker M., De Perrot M., Spiliopoulos A., et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesthesia and Analgesia. 2003;97(6):1558–1565. doi: 10.1213/01.ane.0000087799.85495.8a.
    1. Papazian L., Corley A., Hess D., et al. Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Medicine. 2016;42(9):1336–1349. doi: 10.1007/s00134-016-4277-8.
    1. Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respiratory Care. 2016;61(4):529–541. doi: 10.4187/respcare.04577.
    1. Mazo V., Sabaté S., Canet J., et al. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology. 2014;121(2):219–231. doi: 10.1097/ALN.0000000000000334.
    1. Canet J., Gallart L., Gomar C., et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338–1350. doi: 10.1097/ALN.0b013e3181fc6e0a.
    1. Popat M., Mitchell V., Dravid R., Patel A., Swampillai C., Higgs A. Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia. 2012;67(3):318–340. doi: 10.1111/j.1365-2044.2012.07075.x.
    1. Toffaletti J. G., Rackley C. R. Monitoring oxygen status. Advances in Clinical Chemistry. 2016;77:103–124.
    1. Kammerer T., Speck E., von Dossow V. Anesthesia in thoracic surgery. Anaesthesist. 2016;65(5):397–412. doi: 10.1007/s00101-016-0173-4.
    1. Zhang Z. Univariate description and bivariate statistical inference: the first step delving into data. Annals of Translational Medicine. 2016;4(5, article no. 91) doi: 10.21037/atm.2016.02.11.
    1. Lee J. H., Rehder K. J., Williford L., Cheifetz I. M., Turner D. A. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Medicine. 2013;39(2):247–257. doi: 10.1007/s00134-012-2743-5.
    1. Collins C. L., Holberton J. R., Barfield C., Davis P. G. A randomized controlled trial to compare heated humidified high-flow nasal cannulae with nasal continuous positive airway pressure postextubation in premature infants. Journal of Pediatrics. 2013;162(5):949.e1–954.e1. doi: 10.1016/j.jpeds.2012.11.016.
    1. Futier E., Paugam-Burtz C., Godet T., et al. Effect of early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomised controlled trial (OPERA) Intensive Care Medicine. 2016;42(12):1888–1898. doi: 10.1007/s00134-016-4594-y.
    1. Hernández G., Vaquero C., González P., et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA. 2016;315(13):1354–1361. doi: 10.1001/jama.2016.2711.
    1. Sztrymf B., Messika J., Bertrand F., et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Medicine. 2011;37(11):1780–1786. doi: 10.1007/s00134-011-2354-6.
    1. Kubicka Z. J., Limauro J., Darnall R. A. Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics. 2008;121(1):82–88. doi: 10.1542/peds.2007-0957.
    1. Testa G., Iodice F., Ricci Z., et al. Comparative evaluation of high-flow nasal cannula and conventional oxygen therapy in paediatric cardiac surgical patients: a randomized controlled trial. Interactive Cardiovascular and Thoracic Surgery. 2014;19(3):456–461. doi: 10.1093/icvts/ivu171.
    1. Shepard J. W., Jr., Burger C. D. Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea. American Review of Respiratory Disease. 1990;142(6, part 1):1288–1293. doi: 10.1164/ajrccm/142.6_pt_1.1288.
    1. Spoletini G., Alotaibi M., Blasi F., Hill N. S. Heated humidified high-flow nasal oxygen in adults: Mechanisms of action and clinical implications. Chest. 2015;148(1):253–261. doi: 10.1378/chest.14-2871.
    1. Itagaki T., Okuda N., Tsunano Y., et al. Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically Ill patients. Respiratory Care. 2014;59(1):70–74. doi: 10.4187/respcare.02480.
    1. Corley A., Caruana L. R., Barnett A. G., Tronstad O., Fraser J. F. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. British Journal of Anaesthesia. 2011;107(6):998–1004. doi: 10.1093/bja/aer265.
    1. Riera J., Pérez P., Cortés J., Roca O., Masclans J. R., Rello J. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: A Cohort Study Using Electrical Impedance Tomography. Respiratory Care. 2013;58(4):589–596. doi: 10.4187/respcare.02086.
    1. Roca O., Riera J., Torres F., Masclans J. R. High-flow oxygen therapy in acute respiratory failure. Respiratory Care. 2010;55(4):408–413.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa